Conduit Pharmaceuticals Ownership | Who Owns Conduit Pharmaceuticals?

Conduit Pharmaceuticals Ownership Summary

Conduit Pharmaceuticals is owned by 0.30% institutional investors, and 99.70% retail investors. Karpus Conservative Balanced is the top mutual fund, with 2.31% of its assets in Conduit Pharmaceuticals shares.

MURF Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Conduit Pharmaceuticals	0.30%	-	99.70%
Sector	Financial Services Stocks	43.07%	12.53%	44.40%
Industry	Shell Companies Stocks	29.08%	16.44%	54.49%

Institutional Shareholders

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2023	1	-94.12%	198,925	-87.42%	-	5.26%	-	-100.00%	1	-80.00%
Jun 30, 2023	17	-	1,581,480	-25.30%	2	23.34%	5	-37.50%	5	-44.44%
Mar 31, 2023	17	-55.26%	2,117,044	-80.74%	3	1.16%	8	-50.00%	9	125.00%
Dec 31, 2022	38	40.74%	10,992,632	3.97%	16	6.50%	16	60.00%	4	300.00%
Sep 30, 2022	27	12.50%	10,573,330	9.88%	15	7.55%	10	-58.33%	1	-

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Karpus Conservative Balanced	144.10K	2.31%	-700.00
Karpus Tax Sensitive Fixed Income	129.28K	2.07%	-9.25K
Karpus Taxable Fixed Income	47.70K	0.76%	-700.00
Karpus Growth Balanced	4.88K	0.08%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value

Insider Transactions Trends

Date	Buy	Sell
2023 Q1	-	-

MURF Ownership FAQ

Who Owns Conduit Pharmaceuticals?

Conduit Pharmaceuticals shareholders are primarily institutional investors at 0.30%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Conduit Pharmaceuticals's industry, Shell Companies Stocks , is 29.08%, which Conduit Pharmaceuticals falls below.

Does Blackrock own Conduit Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Conduit Pharmaceuticals.

Who is the top mutual fund holder of Conduit Pharmaceuticals shares?

Karpus Conservative Balanced is the top mutual fund holder of Conduit Pharmaceuticals shares, with 2.31% of its total shares outstanding invested in 144.1K Conduit Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools